TLR4-MyD88-NFκB signaling plays a positive regulatory role in the inflammatory progression of HCC, suggesting that the TLR4-MyD88-NFκB signaling pathway may be a new target for the prevention or treatment of HCC (94). The gene discussed is MYD88; the disease is hepatocellular carcinoma.